Early research (Phase 1)Study completedNCT04397276What this trial is testingJNJ-70218902 in Participants With Advanced Stage Solid TumorsWho this might be right forNeoplasms Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT01487720What this trial is testingGEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Asan Medical Center 33
Early research (Phase 1)Study completedNCT03569280What this trial is testingEvaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC PatientsWho this might be right forCastration-Resistant Prostate Cancer Kangpu Biopharmaceuticals, Ltd. 16
Not applicableStudy completedNCT04962880What this trial is testingHRR Prevalence in LatAm PROSPECT StudyWho this might be right forCastration-resistant Prostate Cancer AstraZeneca 388
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747What this trial is testingAvelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more M.D. Anderson Cancer Center 173
Large-scale testing (Phase 3)Looking for participantsNCT06470243What this trial is testingTesting Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the BodyWho this might be right forCastration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8 SWOG Cancer Research Network 528
Testing effectiveness (Phase 2)Ended earlyNCT04616547What this trial is testingTreatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to BonesWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT02095717What this trial is testingMulticenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)Who this might be right forProstate Cancer Metastatic Castration Resistant Centre Jean Perrin 50
Not applicableAvailableNCT05650476What this trial is testingPre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)Who this might be right forMetastatic Castration-Resistant Prostate Cancer Pfizer
Early research (Phase 1)Study completedNCT03276572What this trial is testingPhase I Trial of 225Ac-J591 in Patients With mCRPCWho this might be right forProstate Cancer Weill Medical College of Cornell University 32
Not applicableUnknownNCT01590498What this trial is testingRadiotherapy vs Observation for CRPCWho this might be right forHormone Refractory Prostate Cancer Zhengzhou University 2,000
Post-approval studies (Phase 4)Looking for participantsNCT06099093What this trial is testingPilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide TetraxetanWho this might be right forProstate CancerMetastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Carcinoma Brigham and Women's Hospital 30
Early research (Phase 1)Study completedNCT03822871What this trial is testingA Trial of CTT1403 for Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Cancer Cancer Targeted Technology 17
Not applicableStudy completedNCT02981797What this trial is testingAssess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223Who this might be right forProstate CancerProstate Adenocarcinoma H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableUnknownNCT02362620What this trial is testingPROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.Who this might be right forAdvanced Prostate CancerCabazitaxelDocetaxel Centro Nacional de Investigaciones Oncologicas CARLOS III 402
Not applicableUnknownNCT03601143What this trial is testingLiquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer PatientsWho this might be right forCastration-resistant Prostate Cancer Technical University of Munich 120
Not applicableStudy completedNCT06809426What this trial is testingEvaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate CancerWho this might be right forPSMA PET-Positive Castration-Resistant Prostate Cancer Affiliated Hospital of Jiangnan University 13
Testing effectiveness (Phase 2)Study completedNCT01543776What this trial is testingFood Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate CancerWho this might be right forCastration-resistant Prostate CancerStage IV Prostate Cancer University of Chicago 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289What this trial is testingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more Rahul Aggarwal 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07104643What this trial is testingStudy of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）Who this might be right formCRPC TYK Medicines, Inc 48